Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxane vs Non-Taxane Regimens and p53 Biomarker in Breast Cancer
NCT00017095Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 2001
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Mar 2001; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00017095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017095.